US 9193790
Use of antagonists of the interaction between HIV GP120 and A4B7 integrin
granted A61KA61K2039/505A61K38/12
Quick answer
US patent 9193790 (Use of antagonists of the interaction between HIV GP120 and A4B7 integrin) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K38/12, A61K39/3955, A61K45/06